Ergosterol Peroxide Isolated from Ganoderma lucidum Abolishes MicroRNA miR-378-Mediated Tumor Cells on Chemoresistance

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Wu, Qing Ping ^a   Xie, Yi Zhen ^a,b   Deng, Zhaoqun ^c,d   Li, Xiang Min ^a   Yang, Weining ^c   Jiao, Chun Wei ^a,c,d   Fang, Ling ^c,d   Li, Sen Zhu ^a,b   Pan, Hong Hui ^a,b   Yee, Albert J ^c   Lee, Daniel Y ^c,d   Li, Chong ^a   Zhang, Zhi ^a   Guo, Jun ^a   Yang, Burton B ^c,d  

^a GUANGDONG INSTITUTE OF MICROBIOLOGY   (China)

^b Guangdong Yuewei Edible Fungi Technology Co Ltd   (China)

^c Canada   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; EPIRUBICIN; ERGOSTEROL PEROXIDE; GANODERMA LUCIDUM EXTRACT; METHOTREXATE; MICRORNA; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DEATH; CELL SURVIVAL; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG PURIFICATION; DRUG RESISTANCE; DRUG SENSITIVITY; GANODERMA LUCIDUM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CERAMIDES; CYTARABINE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ERGOSTEROL; HUMANS; METHOTREXATE; MICRORNAS; REISHI; TRANSFECTION;

GANODERMA LUCIDUM;

EID: 84865583196     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044579     Document Type: Article

References (42)

1. Calin GA, Croce CM, (2006) MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66: 7390-7394.
2. Lee DY, Deng Z, Wang CH, Yang BB, (2007) MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A 104: 20350-20355.
3. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
4. Hutvagner G, Zamore PD, (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science 297: 2056-2060.
5. Lee Y, Ahn C, Han J, Choi H, Kim J, et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
6. Seitz H, Youngson N, Lin SP, Dalbert S, Paulsen M, et al. (2003) Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. Nat Genet 34: 261-262.
7. Zhao Y, Samal E, Srivastava D, (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436: 214-220.
8. Kawasaki H, Taira K, (2003) Retraction: Hes1 is a target of microRNA-23 during retinoic-acid-induced neuronal differentiation of NT2 cells. Nature 426: 100.
9. Croce CM, Calin GA, (2005) miRNAs, cancer, and stem cell division. Cell 122: 6-7.
10. Shatseva T, Lee DY, Deng Z, Yang BB MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J Cell Sci 124: 2826-2836.
11. Shan SW, Lee DY, Deng Z, Shatseva T, Jeyapalan Z, et al. (2009) MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol 11: 1031-1038.
12. Wang CH, Lee DY, Deng Z, Jeyapalan Z, Lee SC, et al. (2008) MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS One 3: e2420.
13. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102: 13944-13949.
14. Ye G, Fu G, Cui S, Zhao S, Bernaudo S,et al. MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance. J Cell Sci 124: 359-368.
15. Fang L, Deng Z, Shatseva T, Yang J, Peng C,et al. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 30: 806-821.
16. Jiang J, Lee EJ, Gusev Y, Schmittgen TD, (2005) Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33: 5394-5403.
17. Hua Z, Lv Q, Ye W, Wong CK, Cai G, et al. (2006) MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia. PLoS ONE 1: e116.
18. Maruyama H, Yamazaki K, Murofushi S, Konda C, Ikekawa T, (1989) Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst. J Pharmacobiodyn 12: 118-123.
19. Gao Y, Zhou S, Wen J, Huang M, Xu A, (2002) Mechanism of the antiulcerogenic effect of Ganoderma lucidum polysaccharides on indomethacin-induced lesions in the rat. Life Sci 72: 731-745.
20. Hsu MJ, Lee SS, Lin WW, (2002) Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. J Leukoc Biol 72: 207-216.
21. Park EJ, Ko G, Kim J, Sohn DH, (1997) Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol Pharm Bull 20: 417-420.
22. el-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, et al. (1998) Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry 49: 1651-1657.
23. Wu TS, Shi LS, Kuo SC, (2001) Cytotoxicity of Ganoderma lucidum triterpenes. J Nat Prod 64: 1121-1122.
24. Shiao MS, (2003) Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chem Rec 3: 172-180.
25. Kohda H, Tokumoto W, Sakamoto K, Fujii M, Hirai Y, et al. (1985) The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes. Chem Pharm Bull (Tokyo) 33: 1367-1374.
26. Murasugi A, Tanaka S, Komiyama N, Iwata N, Kino K, et al. (1991) Molecular cloning of a cDNA and a gene encoding an immunomodulatory protein, Ling Zhi-8, from a fungus, Ganoderma lucidum. J Biol Chem 266: 2486-2493.
27. Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, et al. (1997) The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 70: 699-705.
28. Lieu CW, Lee SS, Wang SY, (1992) The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res 12: 1211-1215.
29. Sliva D, Sedlak M, Slivova V, Valachovicova T, Lloyd FP Jr, et al. (2003) Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Complement Med 9: 491-497.
30. LaPierre DP, Lee DY, Li SZ, Xie YZ, Zhong L, et al. (2007) The ability of versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Res 67: 4742-4750.
31. Xu S, Linher-Melville K, Yang BB, Wu D, Li J Micro-RNA378 (miR-378) regulates ovarian estradiol production by targeting aromatase. Endocrinology 152: 3941-3951.
32. Lee DY, Shatseva T, Jeyapalan Z, Du WW, Deng Z, et al. (2009) A 3′-untranslated region (3′UTR) induces organ adhesion by regulating miR-199a* functions. PLoS One 4: e4527.
33. Yang X, Rutnam ZJ, Jiao C, Wei D, Xie Y, et al. (2012) An anti-let-7 sponge decoys and decays endogenous let-7 functions. Cell Cycle 11.
34. Lee DY, Jeyapalan Z, Fang L, Yang J, Zhang Y,et al. Expression of versican 3′-untranslated region modulates endogenous microRNA functions. PLoS One 5: e13599.
35. Jeyapalan Z, Deng Z, Shatseva T, Fang L, He C,et al. Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res 39: 3026-3041.
36. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123.
37. Zhao S, Ye G, Fu G, Cheng JX, Yang BB, et al. (2011) Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. Int J Oncol 38: 1319-1327.
38. Yee AJ, Akens M, Yang BL, Finkelstein J, Zheng PS, et al. (2007) The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Res 9: R47.
39. Kobori M, Yoshida M, Ohnishi-Kameyama M, Shinmoto H, (2007) Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells. Br J Pharmacol 150: 209-219.
40. Duarte N, Ferreira MJ, Martins M, Viveiros M, Amaral L, (2007) Antibacterial activity of ergosterol peroxide against Mycobacterium tuberculosis: dependence upon system and medium employed. Phytother Res 21: 601-604.
41. Kim DH, Jung SJ, Chung IS, Lee YH, Kim DK, et al. (2005) Ergosterol peroxide from flowers of Erigeron annuus L. as an anti-atherosclerosis agent. Arch Pharm Res 28: 541-545.
42. Kuo YC, Weng SC, Chou CJ, Chang TT, Tsai WJ, (2003) Activation and proliferation signals in primary human T lymphocytes inhibited by ergosterol peroxide isolated from Cordyceps cicadae. Br J Pharmacol 140: 895-906.